News

David Layton, who will become Partners Group’s sole CEO in July, speaks to PEI about the leadership change, opportunities in the defined contribution market and why SPACs have been ‘overdone’.

BlackRock has developed a hearty appetite for Asia-Pacific private markets. Plus: healthcare exits soar and a report exposes the extent of PE's diversity shortcomings. Here's today's brief, for our valued subscribers only.

The asset management giant wants to nearly double its annual private markets activity across Asia-Pacific, Michael Dennis, head of alternatives for the region, tells PEI.

Jim Mahoney, Huron's new managing partner, spoke with Buyouts about how the firm's succession plan prepares it for the years ahead.

Sexism, bias, an entrenched power structure and the 'mommy track' are among the reasons why more women have not been promoted into deal leadership roles, according to our readers.

Lightyear Capital has raised nearly $466 million for its fifth fund, according to an SEC filing.

CalPERS prioritised SMAs and co-investments towards the end of last year in a bid to improve cost efficiency. Plus: what to expect for SPACs in Europe, and LatAm LPs acquire a taste for buyouts. Here's today's brief, for our valued subscribers only.

The $445bn pension's commitments to the lower-fee structures significantly dwarfed its fund commitments in its latest investment report.

In a competitive US healthcare deal market, Accelmed's strategy puts it “below the radar of the big guns,” managing partner Uri Geiger told Buyouts.

The firm is among a group of emerging managers testing a market that has been slow to open up to newcomers.